Profound regression of coronary atherosclerosis with statins. 2006

Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
Department of Internal Medicine, American University of Beirut, Lebanon.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006538 Heptanoic Acids 7-carbon saturated monocarboxylic acids. Acids, Heptanoic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069059 Atorvastatin A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid,Atorvastatin Calcium,Atorvastatin Calcium Anhydrous,Atorvastatin Calcium Hydrate,Atorvastatin Calcium Trihydrate,Atorvastatin, Calcium Salt,CI 981,CI-981,Lipitor,Liptonorm,CI981
D017023 Coronary Angiography Radiography of the vascular system of the heart muscle after injection of a contrast medium. Angiography, Coronary,Angiographies, Coronary,Coronary Angiographies

Related Publications

Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
May 2007, JAMA,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
February 2007, JAMA,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
October 2006, JAMA,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
October 2006, JAMA,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
October 2006, JAMA,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
November 2014, Nature reviews. Cardiology,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
November 1990, The New England journal of medicine,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
January 2008, American journal of cardiovascular drugs : drugs, devices, and other interventions,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
November 2011, Nature reviews. Cardiology,
Mouhamad H Abdallah, and Wassef Karrowni, and Habib A Dakik
April 2017, The New England journal of medicine,
Copied contents to your clipboard!